Skip to content
Research/Hormone Optimization/Fezolinetant

Fezolinetant

Fezolinetant is a neurokinin 3 (NK3) receptor antagonist primarily investigated for its role in managing menopausal symptoms, particularly hot flashes. By modulating the neurokinin B pathway, it helps regulate temperature control and hormonal balance, which can improve quality of life during menopause and potentially impact longevity by optimizing hormonal health.

Intelligence Profile

Science

Fezolinetant is a medication that functions as an antagonist of the neurokinin 3 receptor (NK3R). The mechanism involves blocking the action of neurokinin B (NKB), a neuropeptide that is implicated in the regulation of temperature control and reproductive hormones. This action is particularly relevant to managing vasomotor symptoms such as hot flashes associated with menopause and certain cancer therapies.

The evidence, as referenced in various studies, highlights the specificity of fezolinetant for the NK3R, which is involved in the regulation of gonadotropin-releasing hormone (GnRH) neurons. By inhibiting the NK3R, fezolinetant potentially modulates thermoregulatory and neuroendocrine pathways, alleviating symptoms like hot flashes.

This NK3R antagonistic activity is also being explored in other contexts, such as for men undergoing androgen deprivation therapy for prostate cancer, where similar vasomotor symptoms occur.

Note: This information is intended for educational purposes and should not be taken as medical advice. Always consult healthcare providers for personal medical decisions.